Complement deposition is observed at the platelet surface in more than a half of ITP patients [80,81], and about 30% of ITP patients have at least one complement exploration (C3, C4 or CH50) below the lower range [82]. This evidence concerns the gene C4A and autoimmune thrombocytopenic purpura.